LeadIQ logo
Learn more at LeadIQ.com
DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company Employee Directory

Biotechnology ResearchCalifornia, United States51-200 Employees

At DICE, we are expecting more out of medicine. We design and develop innovative oral medicines against biologically validated targets in immunology for the treatment of chronic autoimmune and inflammatory diseases. Through combining innovative chemistry with well-validated biology, our goal is to make medicines more accessible and unlock the potential of oral medicines.

Our team is led by an exceptional group of scientists, R&D executives and company builders with demonstrated track records of progressing programs from discovery through regulatory approval and commercialization. Together, we’re building a team that has a passion for innovation and extensive experience in small molecule drug discovery and development.

Find DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company employees' phone numbers or email addresses

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company Global Highlights

Location
Employees

North America
89

Minus sign iconPlus sign icon
  • United States Of America
    88
  • Canada
    1

Europe
4

Minus sign iconPlus sign icon
  • Netherlands
    1
  • France
    1
  • Germany
    1
  • Switzerland
    1

Africa
2

Minus sign iconPlus sign icon
  • Uganda
    1
  • Egypt
    1

Asia
1

Minus sign iconPlus sign icon
  • India
    1

DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's Leadership

  • Stylized image of a person
    K. J.
    Chief Executive Officer
    Phone icon
  • Stylized image of a person
    T. L.
    Chief Medical Officer
    Phone icon
  • Stylized image of a person
    J. J.
    Chief Scientific Officer
    Phone icon
  • Stylized image of a person
    C. P.
    Vice President Information Technology
    Phone icon
  • Stylized image of a person
    P. O.
    Vice President Regulatory
    Phone icon
  • Stylized image of a person
    B. J.
    Founder Board Chairman
    Phone icon
  • Stylized image of a person
    J. R.
    President
    Phone icon
  • Stylized image of a person
    T. S.
    Executive Assistant To Chief Executive Officer & Chief Financial Officer
    Phone icon

Contact profiles from DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    A. J.
    Senior Accounting Manager
    Phone icon
    United StatesFlorida
    Oct 21, 2024
  • Stylized image of a person
    C. W.
    Senior Manager, Statistical Programming
    Phone icon
    United StatesCalifornia
    Oct 18, 2024
  • Stylized image of a person
    C. R.
    Sr. Clinical Trial Manager
    Phone icon
    United StatesCalifornia
    Oct 16, 2024
  • Stylized image of a person
    D. W.
    Manager, Document Specialist
    Phone icon
    United States
    Oct 21, 2024
  • Stylized image of a person
    F. N.
    Accounting Manager
    Phone icon
    United StatesCalifornia
    Nov 08, 2024
  • Stylized image of a person
    G. L.
    Manager, Nonclinical Operations
    Phone icon
    United StatesCalifornia
    Nov 08, 2024
  • Stylized image of a person
    G. A.
    Senior Manager, Outsourcing And Vendor Management
    Phone icon
    United StatesCalifornia
    Nov 09, 2023
  • Stylized image of a person
    T. T.
    Contract Manager
    Phone icon
    United StatesCalifornia
    Oct 22, 2024
  • Stylized image of a person
    Y. S.
    Accounting Manager
    Phone icon
    United StatesCalifornia
    Oct 21, 2024
  • Stylized image of a person
    A. P.
    Sr. Cra
    Phone icon
    United StatesCalifornia
    Oct 23, 2024

Frequently Asked Questions

What is DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company known for?

Minus sign iconPlus sign icon
DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company was founded in 2013 operates in the Biotechnology Research industry. The company's main headquarters is located in 279 E. Grand Avenue South San Francisco, CA 94080 US; you can contact the main corporate office by phone at . Explore DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's company overview page for more information.

What is DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's most common email format?

Minus sign iconPlus sign icon
DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company email formats with LeadIQ.

How many employees does DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company have currently?

Minus sign iconPlus sign icon
DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company has approximately 67 employees as of March 2024. These team members are located across 4 continents, including North AmericaEuropeAfrica.

Who are DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's key employees and leadership?

Minus sign iconPlus sign icon

As of March 2024, DICE Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company's key employees include:

  • Chief Executive Officer: K. J.
  • Chief Medical Officer: T. L.
  • Chief Scientific Officer: J. J.
  • Vice President Information Technology: C. P.
  • Vice President Regulatory: P. O.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.